9 Meters Biopharma
NMTR
NMTR was delisted on the 25th of July, 2023.
15 hedge funds and large institutions have $24.3M invested in 9 Meters Biopharma in 2018 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 6 closing their positions.
13,209% more capital invested
Capital invested by funds: $182K → $24.3M (+$24.1M)
100% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 6
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
67% more funds holding
Funds holding: 9 → 15 (+6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$9.54M |
| 2 |
Millennium Management
New York
|
+$1.29M |
| 3 |
Goldman Sachs
New York
|
+$1.25M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$686K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$330K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$24K |
| 2 |
RPG
Risk Paradigm Group
Austin,
Texas
|
-$16.5K |
| 3 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$13K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$11K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$11K |
NMTR Hedge Fund Activity: Q1 2018 in Review
15 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in 9 Meters Biopharma (NMTR) for Q1 2018, worth a combined $24.3M — up 13,209% from $182K a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new NMTR positions and 6 closed out — a net gain of 6 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Sphera Funds Management, opening a new position worth an estimated $9.54M. The largest seller was Virtu Financial, exiting entirely with an estimated $24K sold.
- 15 institutional investors held 9 Meters Biopharma (NMTR) as of Q1 2018, up from 9 in Q4 2017.
- Funds reported $24.3M of 9 Meters Biopharma stock for Q1 2018, up 13,209% quarter-over-quarter.
- 12 funds opened new 9 Meters Biopharma positions in Q1 2018 and 6 closed out, a net change of +6 holders.
- The largest 9 Meters Biopharma buyer in Q1 2018 was Sphera Funds Management, an estimated $9.54M added.
- The largest 9 Meters Biopharma seller in Q1 2018 was Virtu Financial, an estimated $24K sold.
Based on aggregated 13F filings for Q1 2018.